Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Patient preference is key for medication selection in chronic medical conditions, like type 2 diabetes, where there are many different drugs available. Patient preference balances potential efficacy with potential side effects. As both aspects of drug response can vary markedly between individuals t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Med
Main Authors: Shields, Beverley M, Angwin, Catherine D, Shepherd, Maggie H, Britten, Nicky, Jones, Angus G, Sattar, Naveed, Holman, Rury, Pearson, Ewan R, Hattersley, Andrew T
Formato: Artigo
Idioma:Inglês
Publicado em: 2023
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7614215/
https://ncbi.nlm.nih.gov/pubmed/36477734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-022-02121-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados